Figures & data
Figure 1 Subject disposition and pattern of biologic use of patients enrolled into ISAR or CHRONICLE.
![Figure 1 Subject disposition and pattern of biologic use of patients enrolled into ISAR or CHRONICLE.](/cms/asset/3093ef9d-7962-4d61-8279-867942abb935/djaa_a_12166990_f0001_c.jpg)
Figure 2 Proportion of patients with severe asthma enrolled into ISAR or CHRONICLE (n= 3531) on each biologic (first use) by year.
![Figure 2 Proportion of patients with severe asthma enrolled into ISAR or CHRONICLE (n= 3531) on each biologic (first use) by year.](/cms/asset/6564b97a-a02b-4e0d-b9c6-2167e57076f3/djaa_a_12166990_f0002_c.jpg)
Table 1 Pattern of Biologic Use Overall and by Country for Patients with Severe Asthma Enrolled into ISAR and CHRONICLE
Figure 3 Time to biologic cessation for patients with severe asthma enrolled into ISAR or CHRONICLE who stopped or switched biologic (from 2018 onwards).
![Figure 3 Time to biologic cessation for patients with severe asthma enrolled into ISAR or CHRONICLE who stopped or switched biologic (from 2018 onwards).](/cms/asset/599ccf78-5ddb-48e0-a294-0fba71335865/djaa_a_12166990_f0003_c.jpg)
Figure 4 Pattern of biologic switch for patients with severe asthma enrolled into ISAR or CHRONICLE those who switched once (n=377). Patterns are mutually exclusive; │: or, <, >: sequence of switch; +: add-on use.
![Figure 4 Pattern of biologic switch for patients with severe asthma enrolled into ISAR or CHRONICLE those who switched once (n=377). Patterns are mutually exclusive; │: or, <, >: sequence of switch; +: add-on use.](/cms/asset/50e0b7f0-83f2-4d24-9eaa-24eeae314385/djaa_a_12166990_f0004_c.jpg)
Table 2 Demographic and Clinical Characteristics of Patients with Severe Asthma Enrolled into ISAR or CHRONICLE, Prior to First Biologic, According to Pattern of First Biologic Use
Table 3 Reasons Why eCRF Patients with Severe Asthma Enrolled into ISAR or CHRONICLE Stopped or Switched Their First Prescribed Biologic